Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil

Pharmacogenomics Journal

Volumn 2, Issue 1, 2002, Pages 65-68

  Dauvilliers, Y ^a,b   Neidhart, E ^b   Billiard, M ^a   Tafti, M ^b  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Dopamine; Excessive daytime sleepiness; Gender; Sleep

Indexed keywords

AMPHETAMINE; CATECHOL METHYLTRANSFERASE; CLOMIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; MODAFINIL; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; FEMALE; GENE ACTIVITY; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NARCOLEPSY; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SYMPTOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CATECHOL O-METHYLTRANSFERASE; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NARCOLEPSY; SEX CHARACTERISTICS;

EID: 0036360437     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500088     Document Type: Article

References (17)

1. Pharmacological aspects of human and canine narcolepsy
2. MAO-A and COMT polymorphisms and gene effects in narcolepsy
3. Successful treatment of idiopathic hypersomnia and narcolepsy with moclafinil
4. Modafinil: A double-blind multicentric study
5. US Modafinil in Narcolepsy Multicenter Study Group
6. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
7. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat
8. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: Prevention by local GABAA receptor blockade
9. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: Comparison with amphetamine
10. Hypothalamic arousal regions are activated during modafinil-incluced wakefulness
11. Modafinil binds to the dopamine uptake carrier site with low affinity
12. Dopaminergic role in stimulant-induced wakefulness
13. Determination of the D- and L-enantiomers of modafinil in human plasma utilizing liquid-liquid extraction and high-performance liquid chromatography
14. Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects
15. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil
16. Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers
17. Pharmacogenetics and psychopharmacotherapy